Brenton Flynn

Brenton Flynn


Recent articles

3 Reasons to Buy AbbVie Today

Why you should consider buying this pharmaceuticals player and its powerhouse drug today.

Why Apple, Like Tiger Woods, Will Return to Greatness

On Monday, Tiger Woods won the Arnold Palmer Invitational at Bay Hill Country Club to regain his status as the world's No. 1 professional golfer. But what on earth do Tiger Wood and Apple have in common?

Intuitive Surgical's March Madness

The bearish sentiment around Intuitive Surgical won't go away anytime soon, so new investors should be prepared to deal with some volatility over the short term.

Forget Obamacare -- Apple's iPhone Could Help Save Health Care

The jury's still out on whether Obamacare can truly stem the rise in health care costs. However, technology based on Apple's iPhone and other smartphones could be a key tool for saving the system money while helping patients and investors.

Why the Health Care Arms Race Hurts This Stock

Being a middle man isn't fun when you're being pressured by increasingly large customers. The same is true in health care, where one distributor is being hurt by industry consolidation, some of it instigated by Obamacare.

Don't Believe This Obamacare Cost Projection

Before trusting a forecast, make sure you understand the motivations of the people behind the predictions. In the case of a new forecast related to Obamacare's Medicaid expansion, one analyst has his doubts.

Does Merck's Dividend Have Room to Soar?

With its top drug's patent loss hurting sales, and setbacks in the clinic slowing new drugs to market, is Merck's dividend on solid footing?